Zobrazeno 1 - 10
of 10
pro vyhledávání: '"statistical analysis"'
Autor:
Esther Dubrovsky, Deborah Axelrod, Amber A. Guth, Jennifer Chun, Richard L. Shapiro, Freya Schnabel, Shira Schwartz
Publikováno v:
Journal of Clinical Oncology. 35:544-544
544 Background: To examine the trends in clinicopathologic features, treatment, and survival of male breast cancer (MBC), utilizing the National Cancer Data Base (NCDB). Methods: MBC patients entered in the NCDB from 2004-2009 were compared with thos
Autor:
Pablo M. Bedano, Radhika Walling, Shiroo Parshad, Arya Bolla, Janvi Bhatia, Anuj Krishna Agarwala, Gregory William Smith, Sumeet Bhatia, Mary Louise Mayer, Priti Poojary, Bilal Karim Siddiqui, Natraj Reddy Ammakkanavar
Publikováno v:
Journal of Clinical Oncology. 35:102-102
102 Background: Precision genomics medicine is a fast growing in cancer care. Targeted therapy has yielded substantial benefit when appropriately used. With next generation sequencing (NSG) use increasing in non-academic setting outside clinical tria
Autor:
Angeline J Pallante, Joleen M. Hubbard, Brendon Huffman, Samer Alsidawi, Steven R. Alberts, Andrew M. Briggler, Gustavo Figueiredo Marcondes Westin, Chandrikha Chandrasekharan, Thorvardur R. Halfdanarson
Publikováno v:
Journal of Clinical Oncology. 35:420-420
420 Background: Advanced biliary cancers respond poorly to chemotherapy and have a dismal survival. Currently gemcitabine-cisplatin (GC) is the standard of care for patients with advanced disease. The efficacy of second line treatment options is not
Publikováno v:
Journal of Clinical Oncology. 33:471-471
471 Background: To identify predictors of post-operative renal insufficiency by analyzing pre-operative imaging volumetrics among patients undergoing radical nephrectomy (RN) for renal cell carcinoma (RCC). Methods: A retrospective review of all pati
Autor:
Sarah E. James, Shreya Prasad, Paul R. Walker, Tithi Biswas, Timothy M. Zagar, Jimmy T. Efird
Publikováno v:
Journal of Clinical Oncology. 32:e12036-e12036
e12036 Background: Inflammatory breast cancer is a rare but aggressive form of breast cancer. Even with modern chemotherapy along with multimodality therapy, 5-year survival is poor in the range of 30-50%. Knowledge and information about inflammatory
Publikováno v:
Journal of Clinical Oncology. 32:512-512
512 Background: Feasibility of partial nephrectomy for small renal masses extends beyond standard clinical tumor size. We analyze patient characteristics and anatomic tumor factors to determine variables associated with surgical complications after p
Publikováno v:
Journal of Clinical Oncology. 31:e12502-e12502
e12502 Background: Incidence of breast cancer in Asian countries is about one third to one half of that of the US. Asian immigrants have a higher risk of developing breast cancer in the US presumably by adopting more westernized lifestyles. We conduc
Autor:
Andrew M. McDonald, Michael C. Dobelbower, Brian J. Gebhardt, John B. Fiveash, Sejong Bae, Rojymon Jacob, Robert Y. Kim, Karan P. Singh, Eddy S. Yang
Publikováno v:
Journal of Clinical Oncology. 31:175-175
175 Background: To identify post-operative prostate cancer patients who are unlikely to achieve long-term biochemical control following salvage radiotherapy (SRT). We hypothesize that patients with node-positive disease, no nadir after radical prosta
Publikováno v:
Journal of Clinical Oncology. 30:63-63
63 Background: Disparities are found in breast cancer diagnosis, treatment, and outcomes. We seek to determine if socioeconomic and geographic disparities exist nationally in immediate reconstruction type after mastectomy. Methods: This retrospective
Autor:
George J. Bosl, Robert J. Motzer, Dean F. Bajorin, Joel Sheinfeld, Brett S. Carver, Jason Stasi
Publikováno v:
Journal of Clinical Oncology. 23:4581-4581
4581 Background: The integration of chemotherapy and surgery for metastatic non-seminomatous germ cell tumors (NSGCT) results in an overall survival of > 90%. We evaluated NSGCT patients (pts) undergoing post-chemotherapy retroperitoneal lymph node d